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ORIGINAL RESEARCH
Hepatocyte Injury Induced by
Contrast-Enhanced Diagnostic
Ultrasound
Douglas L. Miller, PhD , Xiaofang Lu, MD, Mario Fabiilli, PhD, Chunyan Dou, MD
Objectives—Contrast-enhanced diagnostic ultrasound (US) has a potential to
induce localized biological effects. The potential for contrast-enhanced diagnos-
tic US bioeffects in liver were researched, with guidance from a report by Yang
et al (Ultrasonics 2012; 52:1065–1071).
Methods—Contact and standoff scanning was performed for 10 minutes with a
diagnostic US phased array at 1.6 MHz during bolus injection or infusion of a
contrast agent at a high dose. The impact of the imaging on rat liver was investi-
gated by measuring enzyme release, microvascular leakage, and staining of
injured hepatocytes.
Results—The results showed liver enzyme release at 30 minutes, indicating
liver injury, and elevated extraction of Evans blue dye, indicating microvascular
leakage. In addition, Evans blue and trypan blue vital-staining methods revealed
scattered stained cells within the US scan plane. For the Evans blue method,
fluorescent cell counts in frozen sections were greatest for standoff exposure with
contrast infusion. The count decreased strongly with depth for bolus injection,
which was probably reflective of the high attenuation noted for this agent
delivery method.
Conclusions—The results qualitatively confirmed the report by Yang et al and
additionally showed hepatocyte vital staining. Research is needed to determine
the threshold for the effects and the contrast agent dose response.
Key Words—contrast-enhanced diagnostic ultrasound; diagnostic ultrasound
adverse effects; liver ultrasound imaging; ultrasonic cavitation biology
U ltrasound (US) contrast agents are used to enhance imageswith poor vascular resolution or detail.1 Introduced in the1990s, the agents have been approved for use in visualizing
the left ventricle and aiding endocardial border delineation for
patients with suboptimal echocardiograms. In addition, many other
applications have been explored. Recently, contrast-enhanced
diagnostic ultrasound (CEDUS) of the liver has been established
as a useful method.2 The evaluation of incidental findings of focal
liver lesions appears to be an especially valuable application.3–5
Ultrasound contrast agents are suspensions of stabilized
microbubbles. For example, Definity (perflutren lipid microsphere
injectable suspension; Lantheus Medical Imaging, Inc, North Bil-
lerica, MA) is a solution of lipids supplied in a vial with perflutren
(perfluoropropane) gas, which is shaken (using a dedicated vial
shaker) to produce a suspension of microbubbles with a lipid skin.
Definity is no longer sold for research purposes, but a replacement
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contrast agent can be produced for research by using
a formula mimicking the Definity formula, as
described previously.6 The contrast agent microbub-
bles are coincidentally small enough to circulate with
the blood and have sizes suitable for strong interac-
tion with diagnostic US pulses.7 Diagnostic US pulses
can activate the microbubbles sufficiently to nucleate
US cavitation, a well-known mechanism for biological
effects. The benchmark effect is injury to capillaries as
the microbubbles pulsate violently. This leads to a
progression of local damage with an increasing pulse
pressure amplitude, including endothelial cell injury,
capillary leakage, petechial hemorrhage, and injury to
adjacent parenchymal cells. The resulting microlesion
can then elicit fibrin formation and inflammatory
responses. This potential for patient injury from
CEDUS presents a safety issue, which must be
addressed to ensure the performance of CEDUS
without risk of cavitation-induced patient injury.
Microvascular injury and microlesions have been
reported in several different tissues and organs,
including the intestine,8 cremaster muscle,9 abdomi-
nal muscle,10 heart,11,12 kidney,13,14 and pancreas.15
The effects occur above specific pulse pressure ampli-
tudes (ie, thresholds), and the threshold for petechial
hemorrhage increases approximately in proportion to
the US frequency in the kidney16 and heart,17 with
minimal or no effects for CEDUS above about
5 MHz within the limits of diagnostic US.
The liver has received relatively little research
attention regarding the cavitation safety issue. Shigeta
et al18,19 studied possible bioeffects in rat liver scanned
with an Acuson Sequoia 512 diagnostic US machine
(Siemens Medical Solutions, Mountain View, CA)
with linear and curved arrays using a mechanical index
(MI) value of 0.7 or 1.8 (an exposure index related to
cavitation potential) with continuous scanning for
1 minute. A late-phase exposure (10 seconds) was also
performed to scan microbubbles taken up by Kupffer
cells 5 minutes after administration. The contrast
agents Levovist (air filled with palmitic acid stabiliza-
tion; Schering AG, Berlin, Germany) and DD-723
(later named Sonazoid, perfluorobutane with phospha-
tidyl serine stabilization; Daiichi Sankyo Co, Tokyo,
Japan) were investigated using histology on light and
electron microscopy. Endothelial injury and platelet
aggregates were found in exposed rat livers. Vacuoliza-
tion was seen in hepatocytes, and microbubbles were
observed inside Kupffer cells, likely due to phagocyto-
sis. In addition, increased platelet activation was
observed for in vitro testing in US-plus-contrast agent
groups. The exposures had two aspects, which would
tend to minimize cavitational bioeffects: a relatively
high US frequency (either 8 or 12 MHz) and continu-
ous exposure (which can destroy microbubbles before
they reach the focal region). The platelet activation
seen in vitro, especially with Levovist, may not actually
translate to the in vivo situation.
Yang et al20 used a Vivid 7 Dimension US
machine (GE Vingmed Ultrasound, Horten, Norway)
with an S4 transducer at 1.5 MHz to evaluate the
safety of US-targeted microbubble destruction (related
to use of diagnostic US as a means for gene delivery to
liver cells). The probe was handheld on the depilated
abdomens of rats with a 3-cm image depth. Exposure
to the liver was performed by alternating a low viewing
MI of 0.08 and then switching to a “flash” mode at a
high MI of 1.0, which gave alternating destruction and
refill of microbubbles, and continued for 10 minutes.
The contrast agent Zhifuxian (Xinqiao Hospital,
Chongqing, China) was used as a 500-μL/kg bolus
dose. This agent had lipid stabilization and perfluoro-
propane gas, which was prepared by shaking to yield
4 to 9 (109) mL–1 microbubbles of 2.1 μm in mean
diameter.21 Groups included control, agent only, US
only, and US plus the agent with assessments at 0-,
0.5-, 12-, and 24-hour time points. Evans blue dye was
used as a tracer for vascular permeability in optical
microscopy and tissue extraction, and lanthanum
nitrate was used as a tracer for electron microscopy. In
addition, the liver enzymes alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) were
measured in serum samples as a measure of liver
injury. The US-plus-microbubble groups had Evans
blue extravasation into the parenchyma and lanthanum
detectable in the cytoplasm. The AST and ALT levels
were elevated at 0.5 hours but returned to normal at
24 hours. Overall, the results suggested that CEDUS
increased capillary and cell membrane permeability
with some hepatic toxicity.
The purpose of this study was to evaluate
CEDUS-induced bioeffects in rat liver. The study by
Yang et al20 was used as the initial model because it
appears to be the only account of CEDUS-induced
liver injury. Our GE Vivid 7 Dimension machine was
used with our replacement contrast agent (similar to
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Definity). Results were generally supportive of the
study by Yang et al20 and also indicated hepatocyte
injury by Evans blue staining after application of
intermittent exposure protocols similar to our previ-
ous heart and kidney research.
Materials and Methods
Animal Preparation
This in vivo research was conducted with the
approval of the Institutional Animal Care and Use
Committee at the University of Michigan. Male rats
(Sprague Dawley; Charles River Laboratories, Wil-
mington, MA) with a mean weight of 317 ± 36 g
were used in this study, as detailed below. Six were
lost from the study because of anesthetic death or
technical problems. The rats were anesthetized via
intraperitoneal injection of 40-mg/kg pentobarbital.
The abdomen was shaved and depilated to maximize
US transmission. A 24-gauge cannula was inserted
into a tail vein for intravenous injections and infusion
of the contrast agent. Rats were placed in the dorsal
decubitus position on a warming pad with US trans-
mission gel on the abdomen over the liver. Rats were
scanned either with the US probe directly on the
abdomen or with the probe above the abdomen using
a small water-filled standoff to place the focal zone
within the liver. The standoff design used a thin poly-
ethylene window for transmission. When Evans blue
dye injection was not used, rats were checked for
their heart rate and percentage of oxygen saturation
of hemoglobin in peripheral blood, which averaged
325 ± 18 beats per minute and 81% ± 3%,
respectively.
Diagnostic Ultrasound
Yang et al20 used a GE Vivid 7 Dimension machine
with an S4 transducer placed on the abdomen. The
second harmonic B-mode was used with 1.5-MHz
transmit and 3.2-MHz receive frequencies. A 3-cm
image and focus depth were used with an intermittent
exposure scheme. Low-MI images were used to visu-
alize the arrival of contrast agent microbubbles, and
then the mode was switched to the flash mode at the
maximum MI of 1.0. The high and low modes were
switched rapidly to observe alternating phases of
microbubble destruction and refill in the imaging
plane. The total scan time was 10 minutes.
For this study, an 3S phased array probe
(GE Vivid 7 Dimension) was used with two different
procedures to exposure the right medial lobe of the
liver in a transverse plane. For contact exposure, a
3-cm image and focal depth were used. Our machine
had an octave mode with 1.6-MHz transmit and
3.2-MHz receive frequencies but did not have a flash
mode. The machine was therefore switched quickly
(≈20-second cycle time for refill) between a low MI of
0.1 and a maximum MI of 1.0 at 25.2 frames per sec-
ond, which continued for 10 minutes. This contact
method was somewhat inconsistent because of the
manual operation. For standoff exposure (SE), the
image depth was 8 cm; the focus depth was 5 cm; and
the anterior liver lobe was located at the measured
optimal focus of 3.8 cm by adjusting the position of
the probe. This arrangement was previously used for
studies of contrast-related bioeffects in the rat heart.17
The scan pulse repetition frequency was 4.1 kHz, and
the pulse duration was 1.52 microseconds. A time trig-
ger signal at 1 Hz was directed into the electrocardio-
graphic input and used to set a 10-second intermittent
scan interval. The intermittent triggering allowed refill
of the tissue with the contrast agent between triggered
dual images. This dual-image method can display con-
trast microbubble destruction as a loss of contrast
enhancement for the second image.
The pulse-pressure waveforms were measured in
a water bath using a calibrated hydrophone with a
0.2-mm sensitive spot (HGL0200; Onda, Sunnyvale,
CA), and the peak rarefactional pressure amplitude
was determined at two depths 0.5 cm apart, which
approximately corresponded to the anterior and pos-
terior surfaces of the scanned liver lobe. The depths
were 0.5 and 1.0 cm for the contact exposure condi-
tion and 3.8 cm and 4.3 cm for the standoff exposure
condition. Values are listed in Table 1 for the pulse
parameters and –6-dB scan widths and thicknesses.
For comparison, the dimensions of the active region
of the probe were 1.5 cm (perpendicular to the scan
plane) and 2.1 cm (in the scan plane). Pulse dura-
tions were calculated from the time-intensity integral
of the pulse waveform. The intermittent scans were
performed at the maximum power setting of 0 dB
(MI, 1.3). The standoff method with intermittent
imaging was superior to the contact method both in
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terms of the consistency of exposure and in terms of
the maximum pulse parameters delivered. The con-
tact method was only used for a few tests with
Evans blue.
Ultrasound Contrast Agent
The US contrast agent was a laboratory replacement
for Definity, which is no longer sold for research pur-
poses. A replacement contrast agent for Definity was
created by using a formula mimicking the Definity
formula, as described previously.6 The lipid mixture
was sterilized and aliquoted into empty sterile Defi-
nity vials with the headspace filled with octafluoropro-
pane (HC-218, PurityPlus; Metro Welding Supply,
Detroit, MI). The vials were shaken for 45 seconds in
a VialMix (DuPont Pharmaceuticals Co, Billerica,
MA) before use to produce the suspensions of stabi-
lized microbubbles. The replacement contrast agent
microbubbles were assessed with a Coulter counter
(Multisizer 4; Beckman Coulter, Inc, Indianapolis,
IN).17 The mean diameter was slightly larger at
1.8 ± 0.11 μm diameter than actual Definity micro-
bubbles at 1.6 ± 0.04 μm, but the concentration of
microbubbles in our tests was not substantially differ-
ent from that of Definity at 3.7 ± 0.3 109 mL–1. The
replacement contrast agent was prepared each day,
diluted with sterile saline, and administered as a bolus
dose of 500 μL/kg to reproduce the dosage used by
Yang et al20 or as an infusion of 50 μL/kg/min for
the 10-minute scans. Bolus injection was used for
contact exposures. For standoff exposures, both bolus
dosing and infusion dosing were used in different
groups. These dosages were high compared to clini-
cally recommended doses of Definity (10-μL/kg
bolus or ≈3.7-μL/kg/min infusion for a 70-kg
human). For sham exposure, the rat was scanned for
5 minutes at the maximum US (0 dB) setting, and
then the contrast agent was infused for 10 minutes
with the US off. Examples of the dual images are
shown in Figure 1 before and after contrast delivery.
The bolus injection produced large contrast enhance-
ment at the surface but shadowing, indicative of
increased attenuation, with depth.
Experimental Plan and Measured End Points
In preliminary testing, the US scanning geometry was
established so that the scan plane was located at
about the same position for each rat. However, there
was no identifiable indication of a contrast-enhanced
US–induced effect on the scanned liver samples, in
contrast to the clear indications of petechiae, which
can be shown in the heart22 or kidney.23 Groups of
rats had blood samples taken before and 30 minutes
after scanning for evaluation of liver enzymes, in an
effort to detect liver injury, as reported by Yang
et al.20 Alanine aminotransferase and AST were both
measured (Activity assay kits; Sigma-Aldrich, St
Louis, MO). The liver was perfused with saline and
then with neutral buffered formalin for fixation. His-
tologic slides were made of tissue slabs cut to cross-
section the scan plane to search for injury.
Yang et al20 used Evans blue dye to test for
microvascular leakage. In our studies of bioeffects of
myocardial contrast echocardiography, Evans blue has
been useful for showing microvascular leakage12 and
also for staining lethally injured cardiomyocytes.23
The cardiomyocyte staining can be evaluated by fluo-
rescence microscopy to score numbers of cavitational
microlesions, which consist of a petechial hemorrhage
and one or more injured cardiomyocytes.17 Evans
blue dye was prepared at 50 mg/mL in saline and
injected before US scanning at 50 mg/kg. Liver sam-
ples were obtained 30 minutes after exposure after
perfusion clearance of the circulation with 300 mL of
Table 1. Results for Measurement of US Pulse Parameters in a Water Bath
Test Depth, Pulse Duration, PRPA, PRPA/f½, Thickness, Length,
Method cm μs MPa MPa/MHz½ mm cm
Contact 0.5 1.6 0.86 0.70 12.7 1.55
Contact 1.0 1.9 1.12 0.90 10.0 1.95
Standoff 3.8 1.5 2.47 2.0 5.0 6.9
Standoff 4.3 1.5 2.40 1.9 5.0 7.7
The contact method used 3-cm focus and depth settings with 25.2 frames per second, whereas the standoff method used a 5-cm focus
and an 8-cm depth with 56.3 frames per second. The scan plane area was determined as –6-dB positions crossing the scan plane (thick-
ness) and along the scan plane (length). PRPA indicates peak rarefactional pressure amplitude.
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heparin saline. For evaluation of microvascular leak-
age, liver samples were weighed, minced, and
extracted in formamide. After centrifugation, the
supernatant was measured by spectrophotometry at
620 nm to determine the Evans blue content. In addi-
tion, blue-stained cells were evident on the liver sur-
face within the scan plane. This effect was scored in
frozen sections by fluorescence microscopy. Three
sections cut to cross-section the scan plane (spaced
1.5 mm apart) from each rat liver were scored by
counting fluorescent cells in 5 adjacent × 10 fields of
view from the anterior surface inward to the posterior
surface of the sample. The scoring was performed on
photomicrographic images (Spot Flex; Diagnostic
Instruments, Inc, Sterling Heights, MI) for fixed
exposure times set to maximize the conspicuity of the
stained cells (relative to the background).
The Evans blue appeared to stain the cytoplasm
of hepatocytes, which was not clearly indicative of
lethal injury. A second method of vital staining was
tried using a trypan blue vital stain, based on staining
methods for liver injury.24 After perfusion with hepa-
rin saline, perfusion was continued with 120 mL of
trypan blue solution (10:1 dilution by heparin saline
of 0.4% trypan blue stain; Gibco, Fisher Scientific,
Hampton, NH) followed by 120 mL of heparin
saline. The liver samples showed stained cells in the
scan plane after this procedure. Histologic observa-
tion was also tried using perfusion and immersion fix-
ation with neutral buffered formalin and preparation
of histologic paraffin sections without only the eosin
stain, as reported previously.24 However, the histo-
logic slides did not retain the trypan blue staining suf-
ficiently for confident scoring, and only a qualitative
observation of fresh samples was performed.
The numbers of rats used for the different expo-
sures and tests are listed in Table 2. Results were eval-
uated by comparisons of two means of measurements
in different groups of rats. Statistical analysis was per-
formed with SigmaPlot version 11.0 software for Win-
dows (Systat Software, Inc, San Jose, CA). The
Mann-Whitney rank sum test and the Student t test
were used for the comparisons of unrelated samples,
whereas pared tests were used for comparing before-
and-after tests. Statistical significance was assumed
at P < .05.
Figure 1. Dual US images during exposure using the standoff method with bolus injection (top row) and infusion (bottom row) of the con-
trast agent. The left column shows the preinjection images with the anterior liver lobe about 5 mm thick just below the abdominal wall.
Shadows are produced by the spine and by intestinal gas. When the contrast agent is administered (middle column), the image brightness
is enhanced at the anterior liver, with attenuation shadowing of deeper tissues, especially for the bolus injection. At the end of the
10-minute exposure (right column), the contrast effect is greatly reduced for the bolus injection but still present for the infusion. The contrast
brightness is somewhat reduced for the right image of each pair due to microbubble destruction.
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Results
Enzyme assays were performed for the standoff
method using bolus and infusion contrast delivery.
Results for ALT are shown in Figure 2 as before-and-
after comparisons measured in sham and exposed
samples. The ALT for exposure with contrast infusion
was significantly elevated relative to shams (P < .05).
For AST, the enzyme activity was significantly
increased for both contrast infusion and bolus, and
the after-exposure results was significantly elevated
above the before-exposure results for the contrast
bolus (Figure 3). The enzyme results showed enzyme
release indicative of liver cell injury.
The extraction of Evans blue dye from exposed
liver samples was performed for all of the methods.
Results are shown in Figure 4. Only the exposure
with contrast infusion was significantly increased
(P < .05) above both its respective control samples
(out of the beam path) and sham-exposed samples.
These results indicated that the contact exposure
method was relatively ineffective. In addition, the
standoff exposure with contrast infusion appeared to
be more effective than exposure with the bolus injec-
tion of the contrast agent.
In preliminary tests, freshly excised livers were
examined and fixed for histologic analysis with
hematoxylin-eosin staining to find any clear indica-
tions of injury, such as petechiae, which are seen for
CEDUS of other organs. No bioeffects could be
clearly identified, even after perfusion clearance of the
blood in the circulation. However, both the Evans
blue and the trypan blue methods revealed a band of
scattered stained cells corresponding to the scan
plane in fresh samples. Outside this region, stained
cells were essentially absent, confirming the effect of
US exposure in the scan plane. Examples of the
appearance of the freshly excised livers are shown in
Table 2. Numbers of Rats Used for the Various Exposures and Evaluation Tests
Bolus Bolus Infusion
Test CE CE Sham SE SE Sham SE SE Sham
Enzymes NP NP 7 5 6 5
Evans blue extraction 6 6 8 NP 8 6
Evans blue count 4 4 6 NP 11 10
Trypan blue NP NP 6 NP 6 NP
CE indicates contact exposure; NP, not performed; and SE, standoff exposure.
Figure 2. Results for measurements of plasma ALT in blood sam-
ples taken before and after sham or exposure. The ALT was signifi-
cantly increased (P < .05) for the after-exposure sample with
infusion (#) relative to the sham.
Figure 3. Results for measurements of plasma AST in blood sam-
ples taken before and after sham or exposure. The AST was signifi-
cantly elevated (P < .05) for the after-exposure sample with
infusion relative to sham (#) and for the bolus injection for the
exposed sample relative to both the sham (#) and the before-
exposure sample (*).
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Figure 5. The Evans blue–stained cells showed low
contrast in the bright field, but the trypan blue gave a
readily discernable bluish band, which resulted from
numerous blue-stained cells, in the scan plane.
In frozen sections, the Evans blue–stained cells
could be readily identified by the red fluorescence of
the Evans blue, as shown in Figure 6. There was a
substantial background in some samples, in which
cells were outlined in red fluorescence, possibly due
to incomplete perfusion removal of the dye. However,
the positively stained cells were distinct with bright
fluorescence, which filled in the entire cell. In fresh
tissue slices, the individual trypan blue–stained cells
were readily identified by strong blue staining of the
cell nuclei, as shown in Figure 6 at the same scale as
the Evans blue frozen-section image. Qualitatively,
the scattered distribution and number of affected cells
appeared to be about the same for both staining pro-
cedures. Unfortunately, the fresh hand-cut slices were
thick and uneven so that the staining methods could
not be quantitatively compared. As noted in “Mate-
rials and Methods,” the histologic processing of the
trypan blue–stained samples and staining with eosin
only gave greatly diminished conspicuity of the
stained cells (compared to fresh samples), and these
could not be scored with confidence. The Evans
blue–stained cells could be quantitatively counted,
and the fluorescent cell counts are presented in
Figure 7. The contact exposure method gave
relatively low results compared to the standoff expo-
sure bolus method (P < .01 for the anterior position).
In addition, the standoff exposure method with con-
trast infusion appeared to be more efficacious relative
to the contrast bolus, particularly for deeper portions
of the liver sample (P < .05).
Discussion
Contrast-enhanced diagnostic US has a potential for
induction of localized biological effects, which have
been reported, for example, in muscles, the heart, and
kidneys. The effects include microvascular leakage,
petechial hemorrhage, and lethal injury of parenchy-
mal cells at the highest pulse pressure amplitudes.
The liver is a good candidate for CEDUS examina-
tion, but little research has been reported for
Figure 4. Results for the extraction of Evans blue from liver sam-
ples. For the standoff exposure with infusion of the contrast agent
(*), the extracted Evans blue was significantly elevated (P < .05)
relative to paired controls and to shams.
Figure 5. Stereo microscopic images of freshly excised liver lobes
after perfusion clearance of blood and the dye solution: Evans blue
(top) and trypan blue (bottom). Arrows indicate the position of the
blue band of stained cells within the scan plane; and scale
bars, 1 cm.
Miller et al—Hepatocyte Injury Induced by Contrast-Enhanced Diagnostic Ultrasound
J Ultrasound Med 2019; 38:1855–1864 1861
potential bioeffects in the liver. In this study, the
potential for bioeffects was researched in rat livers,
following a report by Yang et al20 of CEDUS-induced
liver enzyme release, and vascular permeabilization.
The methods of Yang et al20 were used as much
as possible, although our US machine was not capable
of duplicating their exposures. The contact exposure
method placed the liver lobe in the near field of the
probe and delivered reduced exposure levels
compared to the focal zone (Table 1). Our study
included mostly focal zone exposure using a standoff,
which provided higher exposure levels in the anterior
liver lobe and was similar to previous research in
other organs. The large bolus dose produced high
attenuation, evident in the US images (Figure 1). In
our study, we added exposure with 10-second inter-
mittent scans and infusion of the contrast agent,
which reduced attenuation and shadowing.
The results showed enzyme release for 30-minute
samples (Figures 2 and 3). In addition, extraction of
Evans blue dye from the exposed tissue showed a sig-
nificant increase for the standoff exposure method
within contrast infusion (Figure 4). Therefore, the
findings of Yang et al20 were confirmed qualitatively,
even though the methods could not be quantitatively
compared.
In addition, we found that Evans blue and trypan
blue vital-staining methods revealed a band of scat-
tered stained cells corresponding to the US scan
plane (Figure 5). Both methods appeared to detect
about the same distribution and number of stained
cells (Figure 6), which indicates lethal injury of some
hepatocytes. The level of injury was small, less than
1% of cells, but nevertheless quite clearly defined. For
the Evans blue method, a key step was perfusion
clearance of the blood. Even lengthy perfusion clear-
ance left a substantial background in the form of a
fluorescent border around many hepatocytes. This
was not a bioeffect of the CEDUS and may simply
Figure 6. Images of the Evans blue–stained cells for fluorescence microscopy of a frozen section (left) and trypan blue–stained cells for
stereomicroscopy of a freshly cut sample (right). Both samples had standoff exposure with contrast infusion. Scale bars indicate 0.5 mm.
Figure 7. Results for Evans blue–stained cells counted in fluores-
cent microscopy of frozen sections. Five fields of view were scored
for each sample lobe, from the anterior surface (0 mm) inward
toward the posterior side. The strong decrease of the score with
depth for the bolus injection and standoff exposure probably
reflects the attenuation produced by the high contrast agent dose
(see Figure 1).
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have shown remaining Evans blue, possibly within the
space of Disse, which was not cleared by the perfu-
sion blood clearance step. Although the trypan blue
method was not amenable to quantitative histologic
characterization, the Evans blue method gave quanti-
tative fluorescent cell counts as a function of depth
into the liver samples (Figure 7). These results
showed a strong decrease with depth for bolus injec-
tion, probably reflective of the high attenuation noted
for this agent delivery method.
Given the high contrast agent doses, the effects
in this study seemed relatively small, for example,
compared to the heart.17 However, the dose was suffi-
cient to produce substantial attenuation, possibly
reducing the exposure impact. In addition, the low
microvascular impact may be due to the nature of the
sinusoidal capillaries present in the liver, which are
large (7–15 μm in diameter) and lined by discontinu-
ous endothelium.25 Recent research indicates that the
capillaries, for example, in the kidney are injured by
the action of the largest microbubbles in contrast
agents, and microbubble expansion sufficient to stress
capillary walls is required for capillary rupture.26,27
The minimal impact on liver sinusoids may be related
to the limited number of large microbubble sizes
available after passage through the lungs. Further
work has been pursued to better define the bioeffect
response in terms of both the contrast agent dosage
and microbubble sizes and the US pulse amplitude
threshold for the hepatocyte injury, and results have
been reported in a separate article.28
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